InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Oldakowski Mark, Chief Executive Officer. Insider active across 3 companies, notably Bionano Genomics, Inc. Cumulatively, 14 disclosures have been logged. Activity tracked since 12 May 2021. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Oldakowski Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
27 shares@ US$1.300.0002% mcap0.0% of flowCommon StockSEC:0001745566-26-000006:0
20 shares@ US$1.100.0% of flowCommon StockSEC:0001745566-26-000004:0
59 shares@ US$4.060.2% of flowCommon StockSEC:0001745566-25-000007:0
59 shares@ US$4.060.2% of flowCommon StockSEC:0001745566-25-000005:0
27 shares@ US$3.690.1% of flowCommon StockSEC:0001411690-25-000056:0
20 shares@ US$5.730.1% of flowCommon StockSEC:0001411690-25-000019:0
3,568 shares@ US$0.481.8% of flowCommon StockSEC:0001411690-24-000053:0
16,000 shares0Common StockSEC:0001415889-24-015624:0
1,229 shares@ US$1.271.7% of flowCommon StockSEC:0001415889-24-006810:0
20,000 shares0Common StockSEC:0001209191-23-050186:0
41,496 shares@ US$0.6629.7% of flowCommon StockSEC:0001411690-23-000030:0
120,000 shares0Common StockSEC:0001209191-23-010920:0
41,496 shares@ US$1.410.34% mcap100.0% of flowCommon StockSEC:0001209191-22-029458:0
240,000 shares0Common StockSEC:0001209191-21-032932:0
14 of 14 declarations
About Oldakowski Mark
Mark Oldakowski is Directeur Général. He has 14 filings, and across the 14 sampled filings between 2021-05-14 and 2026-06-03, the modal transaction nature is tax withholding, with sum_buy_eur at 0 and sum_sell_eur at 0.
